Digital Screening for Atrial Fibrillation to Prevent Stroke
Recruiting · NCT07684053 · Interventional (participants receive a specific treatment) · Lead sponsor: Medical University Innsbruck
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.
Who can take part
Inclusion criteria
- Age ≥ 65 years
- Policyholder in Austria (active unique social insurance number)
- Written electronic informed consent
Exclusion criteria
- a) Currently treated with oral anticoagulation b) Cardiac implanted electronic device (CIED)
Where it is running
1 location listed.
- Department of Internal Medicine III, Medical University Innsbruck - Innsbruck, Tyrol, Austria